Moreover, the signaling transduced by these receptors can even interfere in the tumor vascular network, an effect experimentally demonstrated by Bogdanovich et al. Bevacizumab was found to inhibit angiogenesis via Fc-mediated signaling through FcγR in a VEGF-independent manner (47). Here, VEGFA is linked to neoplasm.